Logo image of ALENO.PA

ENOGIA SAS (ALENO.PA) Stock Fundamental Analysis

Europe - EPA:ALENO - FR0014004974 - Common Stock

4.57 EUR
+0.13 (+2.93%)
Last: 9/26/2025, 7:00:00 PM
Fundamental Rating

3

ALENO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 63 industry peers in the Electrical Equipment industry. ALENO may be in some trouble as it scores bad on both profitability and health. ALENO shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ALENO had negative earnings in the past year.
ALENO had negative earnings in each of the past 5 years.
ALENO had a negative operating cash flow in each of the past 5 years.
ALENO.PA Yearly Net Income VS EBIT VS OCF VS FCFALENO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

The Return On Assets of ALENO (-4.40%) is worse than 60.32% of its industry peers.
ALENO has a Return On Equity of -12.48%. This is in the lower half of the industry: ALENO underperforms 61.90% of its industry peers.
Industry RankSector Rank
ROA -4.4%
ROE -12.48%
ROIC N/A
ROA(3y)-15.16%
ROA(5y)-16.28%
ROE(3y)-43.3%
ROE(5y)-107.28%
ROIC(3y)N/A
ROIC(5y)N/A
ALENO.PA Yearly ROA, ROE, ROICALENO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

The Gross Margin of ALENO (75.30%) is better than 96.83% of its industry peers.
ALENO's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALENO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.11%
GM growth 5Y-12.18%
ALENO.PA Yearly Profit, Operating, Gross MarginsALENO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

2

2. Health

2.1 Basic Checks

ALENO does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALENO has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ALENO has been increased compared to 5 years ago.
ALENO has a worse debt/assets ratio than last year.
ALENO.PA Yearly Shares OutstandingALENO.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M
ALENO.PA Yearly Total Debt VS Total AssetsALENO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

ALENO has an Altman-Z score of 1.42. This is a bad value and indicates that ALENO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALENO (1.42) is worse than 61.90% of its industry peers.
ALENO has a Debt/Equity ratio of 0.72. This is a neutral value indicating ALENO is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.72, ALENO is doing worse than 63.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Altman-Z 1.42
ROIC/WACCN/A
WACC7.64%
ALENO.PA Yearly LT Debt VS Equity VS FCFALENO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

ALENO has a Current Ratio of 1.54. This is a normal value and indicates that ALENO is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.54, ALENO perfoms like the industry average, outperforming 53.97% of the companies in the same industry.
A Quick Ratio of 1.53 indicates that ALENO should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.53, ALENO is doing good in the industry, outperforming 76.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 1.53
ALENO.PA Yearly Current Assets VS Current LiabilitesALENO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 60.77% over the past year.
ALENO shows a strong growth in Revenue. In the last year, the Revenue has grown by 57.98%.
ALENO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.85% yearly.
EPS 1Y (TTM)60.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.33%
Revenue 1Y (TTM)57.98%
Revenue growth 3Y39.7%
Revenue growth 5Y25.85%
Sales Q2Q%62.16%

3.2 Future

ALENO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 100.00% yearly.
Based on estimates for the next years, ALENO will show a very strong growth in Revenue. The Revenue will grow by 37.95% on average per year.
EPS Next Y200%
EPS Next 2Y144.95%
EPS Next 3Y100%
EPS Next 5YN/A
Revenue Next Year50%
Revenue Next 2Y41.42%
Revenue Next 3Y37.95%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALENO.PA Yearly Revenue VS EstimatesALENO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M
ALENO.PA Yearly EPS VS EstimatesALENO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1

2

4. Valuation

4.1 Price/Earnings Ratio

ALENO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 44.37, which means the current valuation is very expensive for ALENO.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALENO is on the same level as its industry peers.
ALENO's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.89.
Industry RankSector Rank
PE N/A
Fwd PE 44.37
ALENO.PA Price Earnings VS Forward Price EarningsALENO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALENO.PA Per share dataALENO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

ALENO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALENO's earnings are expected to grow with 100.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y144.95%
EPS Next 3Y100%

0

5. Dividend

5.1 Amount

ALENO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ENOGIA SAS

EPA:ALENO (9/26/2025, 7:00:00 PM)

4.57

+0.13 (+2.93%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.52%
Inst Owner ChangeN/A
Ins Owners26.37%
Ins Owner ChangeN/A
Market Cap28.75M
Analysts86.67
Price Target5.61 (22.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)71.88%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 44.37
P/S 3.59
P/FCF N/A
P/OCF N/A
P/B 3.72
P/tB 34.22
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)0.1
Fwd EY2.25%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.27
BVpS1.23
TBVpS0.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.4%
ROE -12.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.3%
FCFM N/A
ROA(3y)-15.16%
ROA(5y)-16.28%
ROE(3y)-43.3%
ROE(5y)-107.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.11%
GM growth 5Y-12.18%
F-ScoreN/A
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.54
Quick Ratio 1.53
Altman-Z 1.42
F-ScoreN/A
WACC7.64%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.33%
EPS Next Y200%
EPS Next 2Y144.95%
EPS Next 3Y100%
EPS Next 5YN/A
Revenue 1Y (TTM)57.98%
Revenue growth 3Y39.7%
Revenue growth 5Y25.85%
Sales Q2Q%62.16%
Revenue Next Year50%
Revenue Next 2Y41.42%
Revenue Next 3Y37.95%
Revenue Next 5YN/A
EBIT growth 1Y56.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A